Deciphera Pharmaceuticals, Inc.

NASDAQ:DCPH

25.59 (USD) • At close June 10, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 44.99948.29443.31338.30433.44536.34535.97432.49429.22324.19923.2223.57325.15619.48615.4497.090.062002500000000000
Cost of Revenue 3.6851.7851.2860.1730.4883.2453.3441.7990.3820.5180.9171.2750.2220.1270.090.008000000000000000
Gross Profit 41.31446.50942.02738.13132.95733.132.6330.69528.84123.68122.30322.29824.93419.35915.3597.0820.062002500000000000
Gross Profit Ratio 0.9180.9630.970.9950.9850.9110.9070.9450.9870.9790.9610.9460.9910.9930.9940.999100100000000000
Reseach & Development Expenses 57.38458.59962.46358.29654.76548.06647.48544.85847.41274.93266.44459.98455.68152.28849.21346.08151.38846.63640.37434.81135.78927.35620.6317.97616.92515.6589.7518.4465.6596.5374.717
General & Administrative Expenses 0000000000000000044.37917.97913.16413.2366.4745.2594.4535.0264.682.432.2442.0671.9971.35
Selling & Marketing Expenses 00000000000000000-20.6420000000000000
SG&A 32.77739.14833.25232.6131.44932.19530.02629.62528.32137.15135.52732.82830.74730.0730.14329.93323.93623.73717.97913.16413.2366.4745.2594.4535.0264.682.432.2442.0671.9971.35
Other Expenses 000000000000000000000000000.166000.002-0.006
Operating Expenses 90.16197.74795.71590.90686.21480.26177.51174.48375.733112.083101.97192.81286.42882.35879.35676.01475.32470.37358.35347.97549.02533.8325.88922.42921.95120.33812.18110.697.7268.5346.067
Operating Income -48.847-51.238-53.688-52.775-53.257-47.161-44.881-43.788-47.675-88.401-79.668-70.514-61.494-62.999-63.997-68.932-75.262-70.373-58.353-22.975-49.025-33.83-25.889-22.429-21.951-20.338-12.181-10.69-7.726-8.534-6.067
Operating Income Ratio -1.086-1.061-1.24-1.378-1.592-1.298-1.248-1.348-1.631-3.653-3.431-2.991-2.445-3.233-4.142-9.722-1,213.90300-0.91900000000000
Total Other Income Expenses Net 3.7644.4794.1074.2133.6481.9261.8380.7270.783-0.006-0.170.0810.1960.2590.2961.6912.4553.1572.1571.5151.6411.5311.4540.7390.5210.4260.1660.0650.0170.002-0.006
Income Before Tax -45.083-46.759-49.581-48.562-49.609-45.235-43.043-43.061-46.892-88.396-79.838-70.433-61.298-62.74-63.701-67.241-72.807-67.216-56.196-21.46-47.384-32.299-24.435-21.69-21.43-19.912-12.038-10.625-7.709-8.557-6.099
Income Before Tax Ratio -1.002-0.968-1.145-1.268-1.483-1.245-1.197-1.325-1.605-3.653-3.438-2.988-2.437-3.22-4.123-9.484-1,174.30600-0.85800000000000
Income Tax Expense 00.431-0.4650-0.6080.7-3.676-1.454-0.7830.0060000.2590.2961.6912.4552.7242.1741.541.6541.4521.4750.760.5430.4490.150.0890.0420.0270.02
Net Income -45.083-47.19-49.581-48.562-49.609-45.935-39.367-41.607-46.109-88.395-79.838-70.433-61.298-62.74-63.701-67.241-72.807-67.216-56.196-21.46-47.384-32.299-24.435-21.69-21.43-19.912-12.038-10.625-7.709-8.557-6.099
Net Income Ratio -1.002-0.977-1.145-1.268-1.483-1.264-1.094-1.28-1.578-3.653-3.438-2.988-2.437-3.22-4.123-9.484-1,174.30600-0.85800000000000
EPS -0.52-0.54-0.58-0.57-0.6-0.6-0.5-0.58-0.79-1.51-1.37-1.21-1.06-1.11-1.13-1.2-1.36-1.31-1.28-0.56-1.25-0.86-0.65-0.65-0.66-0.61-5.85-0.35-0.37-0.41-0.29
EPS Diluted -0.52-0.54-0.58-0.57-0.6-0.6-0.5-0.58-0.79-1.51-1.37-1.21-1.06-1.11-1.13-1.2-1.36-1.31-1.28-0.56-1.25-0.86-0.65-0.65-0.66-0.61-5.85-0.35-0.37-0.41-0.29
EBITDA -47.25-50.782-53.688-52.204-53.257-47.161-44.139-42.968-46.892-88.402-78.909-69.771-60.762-62.045-63.035-66.757-72.347-67.204-56.01-21.323-47.267-32.279-24.326-21.595-21.352-19.84-12.015-10.57-7.653-8.502-6.051
EBITDA Ratio -1.05-1.052-1.24-1.363-1.592-1.298-1.227-1.322-1.605-3.653-3.398-2.96-2.415-3.184-4.08-9.416-1,166.88700-0.85300000000000